Catheter Precision, Inc. (VTAK) Research
Catheter Precision, Inc., headquartered in Fort Mill, South Carolina, is dedicated to creating and distributing electrophysiology products. Their mission is to enhance treatment and outcomes for U.S. patients suffering from cardiac arrhythmias by providing innovative technologies and solutions to patients, hospitals, and physicians. Their premier product, the View into Ventricular Onset System (VIVO), is a non-invasive 3D cardiac mapping solution designed to accurately locate the origin points of idiopathic ventricular arrhythmias in patients with otherwise healthy hearts, before they undergo electrophysiology procedures. Additionally, they offer LockeT, a device for suture retention, and the Amigo Remote Catheter System, a robotic arm used for precise catheter control. The company, previously known as Ra Medical Systems, Inc., officially adopted the name Catheter Precision, Inc. in August 2023.
Market snapshot
- Symbol
- VTAK
- Price
- $0.84
- Day change
- -11.58%
- Market cap
- $907.6K
- P/E ratio
- -124.17x
- 52-week range
- 0.75-6.27
- Sector
- Healthcare
- Industry
- Medical - Devices
- Next earnings
- in 2 months
Peer companies
Recent insider activity
- JENKINS DAVID A — A-Award (40000 shares) on 2026-03-26
- ANDERSON PHILIP J — A-Award (40000 shares) on 2026-03-26
- Arno Andrew — A-Award (40000 shares) on 2026-03-26
- Caruso James Joseph — A-Award (40000 shares) on 2026-03-26
- COLOMBATTO MARTIN J — A-Award (40000 shares) on 2026-03-26
Open Catheter Precision, Inc. (VTAK) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.